Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delay Discounting | 3 | 2021 | 3 | 1.350 |
Why?
|
| Food Preferences | 2 | 2021 | 23 | 1.220 |
Why?
|
| Fibroblasts | 2 | 2019 | 5 | 1.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2019 | 5 | 1.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 689 | 1.010 |
Why?
|
| Obesity | 3 | 2021 | 821 | 0.860 |
Why?
|
| Prediabetic State | 1 | 2025 | 62 | 0.860 |
Why?
|
| Stuttering | 1 | 2023 | 1 | 0.790 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 7 | 0.690 |
Why?
|
| Atherosclerosis | 1 | 2021 | 53 | 0.650 |
Why?
|
| Curcumin | 1 | 2019 | 1 | 0.600 |
Why?
|
| Acetylcysteine | 1 | 2019 | 2 | 0.600 |
Why?
|
| Epithelial Cells | 1 | 2019 | 4 | 0.600 |
Why?
|
| Oxidative Stress | 1 | 2019 | 11 | 0.600 |
Why?
|
| Chemokines, CXC | 1 | 2018 | 1 | 0.550 |
Why?
|
| Receptors, CXCR4 | 1 | 2018 | 2 | 0.550 |
Why?
|
| Transcriptome | 1 | 2018 | 26 | 0.550 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 23 | 0.530 |
Why?
|
| Psychometrics | 1 | 2018 | 119 | 0.530 |
Why?
|
| Risk-Taking | 1 | 2018 | 101 | 0.520 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2023 | 540 | 0.510 |
Why?
|
| Economics, Behavioral | 1 | 2016 | 4 | 0.480 |
Why?
|
| Humans | 12 | 2025 | 17622 | 0.480 |
Why?
|
| Adult | 6 | 2025 | 7621 | 0.470 |
Why?
|
| Alveolar Epithelial Cells | 3 | 2024 | 3 | 0.400 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 1976 | 0.270 |
Why?
|
| California | 2 | 2025 | 2433 | 0.260 |
Why?
|
| Retrospective Studies | 2 | 2025 | 2502 | 0.260 |
Why?
|
| Animals | 4 | 2024 | 285 | 0.250 |
Why?
|
| Adolescent | 2 | 2025 | 3625 | 0.240 |
Why?
|
| Female | 4 | 2025 | 12715 | 0.230 |
Why?
|
| Young Adult | 2 | 2025 | 2538 | 0.230 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 1296 | 0.230 |
Why?
|
| Endoribonucleases | 1 | 2024 | 1 | 0.210 |
Why?
|
| Murine hepatitis virus | 1 | 2024 | 1 | 0.210 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 1 | 0.210 |
Why?
|
| Homeostasis | 1 | 2024 | 11 | 0.210 |
Why?
|
| Pandemics | 1 | 2025 | 295 | 0.200 |
Why?
|
| Male | 3 | 2025 | 10014 | 0.190 |
Why?
|
| Housing | 1 | 2023 | 37 | 0.190 |
Why?
|
| Aged | 2 | 2025 | 6223 | 0.190 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 1 | 0.180 |
Why?
|
| Incidence | 1 | 2025 | 1278 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 2 | 0.180 |
Why?
|
| Communication | 1 | 2023 | 181 | 0.180 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 5 | 0.180 |
Why?
|
| Middle Aged | 2 | 2025 | 7954 | 0.170 |
Why?
|
| Lung Injury | 1 | 2021 | 1 | 0.170 |
Why?
|
| Autophagy | 1 | 2021 | 3 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 11 | 0.170 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 23 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2021 | 22 | 0.170 |
Why?
|
| Skull Base Neoplasms | 1 | 2020 | 1 | 0.160 |
Why?
|
| Cranial Fossa, Middle | 1 | 2020 | 1 | 0.160 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2 | 0.160 |
Why?
|
| Meningioma | 1 | 2020 | 2 | 0.160 |
Why?
|
| Cells, Cultured | 1 | 2019 | 14 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 3 | 0.150 |
Why?
|
| Cell Survival | 1 | 2019 | 10 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 51 | 0.150 |
Why?
|
| Antioxidants | 1 | 2019 | 40 | 0.150 |
Why?
|
| Chemokine CXCL12 | 1 | 2018 | 3 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 9 | 0.140 |
Why?
|
| Disease Progression | 1 | 2018 | 266 | 0.130 |
Why?
|
| Physical Exertion | 1 | 2016 | 14 | 0.120 |
Why?
|
| Risk Factors | 1 | 2021 | 3291 | 0.100 |
Why?
|
| Mice | 2 | 2024 | 82 | 0.100 |
Why?
|
| eIF-2 Kinase | 1 | 2024 | 1 | 0.050 |
Why?
|
| Unfolded Protein Response | 1 | 2024 | 1 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2024 | 4 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 16 | 0.050 |
Why?
|
| Betacoronavirus | 1 | 2024 | 36 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2024 | 49 | 0.050 |
Why?
|
| Proteostasis | 1 | 2021 | 1 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 7 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 11 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 19 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 11 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 33 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2021 | 48 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 7 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 5 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2021 | 10 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 9 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 154 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 133 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 384 | 0.040 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->